OMB APPROVAL
OMB Number. 3235-0145
Expires: Oct. 31, 1994
Estimated average burden
Hours per response..14.90
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
Under the Securities Exchange Act of 1934
(Amendment No. 7)*
Advanced Medical Products Inc.
(Name of Issuer)
Common Stock, $0.01 par value
(Title of Class of Securities)
00753W 20 7
(CUSIP Number)
Check the following line if a fee is being paid with this statement .
(A fee is not required only if the filing person: (1) has a previous
statement on file reporting beneficial ownership of more than five percent of
the class of securities described in Item 1; and (2) has filed an amendment
subsequent thereto reporting beneficial ownership of five percent or less of
such class.) (See Rule 13d-7).
*The remainder of this cover page shall be filled out for a reporting
person's initial filing on this form with respect to the subject class of
securities, and for any subsequent amendment containing information which
would alter the disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not be
deemed to be "filed" for the purpose of Section 18 of the Securities Exchange
Act of 1934 ("Act") or otherwise subject to the liabilities of that section
of the Act but shall be subject to all other provisions of the Act (however,
see the Notes).
Page 1 of 6 pages
CUSIP No. 00753W 20 7 13G Page 2 of 6 pages
1. Name of Reporting Person
S.S. or I.R.S. Identification No. of Above Person
Mr. James Herbert Brown
2. Check the appropriate line if a member of a group*
(a)
(b) X
3. SEC Use Only
4. Citizenship or Place of Organization
United States of America
Number Of 5. Sole Voting Power
Shares 147,816.75
Beneficially 6. Shared Voting Power
Owned By 14,242
Each 7. Sole Dispositive Power
Reporting 147,816.75
Person 8. Shared Dispositive Power
With 2,342
9. Aggregate Amount Beneficially Owned by Each Reporting Person
162,058.75
10. Check if the Aggregate Amount in Row (9) Excludes Certain Shares*
11. Percent of Class Represented by Amount in Row 9
6.0%
12. Type of Reporting Person*
IN
Page 3 of 6 Pages
Item 1.
(a) Name of Issuer:
Advanced Medical Products Inc.
(b) Address of Issuer's Principal Executive Offices:
111 Research Drive
Columbia, South Carolina 29203
Item 2.
(a) Name:
Mr. James Herbert Brown
(b) Address of Principal Business Office:
111 Research Drive
Columbia, South Carolina 29203
(c) Citizenship
United States of America
(d) Title of Class of Securities:
Common Stock, par value $.01 per share
(e) CUSIP Number:
00753W 20 7
Item 3. If this statement is filed pursuant to Rule 13d-1(b) or 13d-2(b),
check whether the person is a:
Not Applicable
Item 4. Ownership
(a) Amount Beneficially Owned as of December 31, 1995:
162,058.75 Shares
Page 4 of 6 Pages
(b) Percent of Class:
6.0%
(c) (i) Sole Power to Vote or to Direct to Vote:
147,816.75 Shares
(ii) Shared Power to Vote or to Direct the Vote:
14,242 Shares
(iii) Sole Power to Dispose or to Direct the Disposition of:
147,816.75 Shares
(iv) Shared Power to Dispose or to Direct the Disposition of:
14,242 Shares
The above shares do not include options for 75,000 shares, the
vesting and exercise formula and schedule of which are set forth in
the Issuer's Amended and Restated Stock Option Plan.
Item 5. Ownership of Five Percent or Less or a Class.
Not Applicable
Item 6: Ownership of More than Five Percent on Behalf of Another Person.
Mr. Brown holders proxies to vote 14,242 shares, which are
owned by immediate family members. The foregoing 14,242 shares are
included in the responses to items 4(c)(ii) and 4(c)(iv).
Item 7. Identification and Classification of the Subsidiary Which Acquired
the Security Being Reported on by the Parent Holding Company.
Not Applicable
Item 8. Identification and Classification of Members of the Group.
Not Applicable
Page 5 of 6 Pages
Item 9. Notice of Dissolution of Group.
Not Applicable
Item 10. Certification.
Not Applicable
Page 6 of 6 Pages
SIGNATURE
After reasonable inquiry and to the best of knowledge and belief,
I certify that the information set forth in this Statement is true, complete
and correct.
/s/JAMES HERBERT BROWN February 14, 1996
JAMES HERBERT BROWN
<PAGE>
OMB APPROVAL
OMB Number. 3235-0145
Expires: Oct. 31, 1994
Estimated average burden
hours per response..14.90
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
Under the Securities Exchange Act of 1934
(Amendment No. 7)*
Advanced Medical Products Inc.
(Name of Issuer)
Common Stock, $0.01 par value
(Title of Class of Securities)
00753W 20 7
(CUSIP Number)
Check the following line if a fee is being paid with this statement .
(A fee is not required only if the filing person: (1) has a previous
statement on file reporting beneficial ownership of more than five percent of
the class of securities described in Item 1; and (2) has filed an amendment
subsequent thereto reporting beneficial ownership of five percent or less of
such class.) (See Rule 13d-7).
*The remainder of this cover page shall be filled out for a reporting
person's initial filing on this form with respect to the subject class of
securities, and for any subsequent amendment containing information which
would alter the disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not be
deemed to be "filed" for the purpose of Section 18 of the Securities Exchange
Act of 1934 ("Act") or otherwise subject to the liabilities of that section
of the Act but shall be subject to all other provisions of the Act (however,
see the Notes).
Page 1 of 6 pages
CUSIP No. 00753W 20 7 13G Page 2 of 6 pages
1. Name of Reporting Person
S.S. or I.R.S. Identification No. of Above Person
Mr. Clarence P. Groff
2. Check the appropriate line if a member of a group*
(a)
(b) X
3. SEC Use Only
4. Citizenship or Place of Organization
United States of America
Number Of 5. Sole Voting Power
Shares 984,366.75
Beneficially 6. Shared Voting Power
Owned By
Each 7. Sole Dispositive Power
Reporting 619,666.75
Person 8. Shared Dispositive Power
With None
9. Aggregate Amount Beneficially Owned by Each Reporting Person
984,366.75
10. Check if the Aggregate Amount in Row (9) Excludes Certain Shares*
11. Percent of Class Represented by Amount in Row 9
36.6%
12. Type of Reporting Person*
IN
Page 3 of 6 Pages
Item 1.
(a) Name of Issuer:
Advanced Medical Products Inc.
(b) Address of Issuer's Principal Executive Offices:
111 Research Drive
Columbia, South Carolina 29203
Item 2.
(a) Name:
Mr. Clarence P. Groff
(b) Address of Principal Business Office:
231 N. Woodlake Drive
Columbia, South Carolina 29223
(c) Citizenship
United States of America
(d) Title of Class of Securities:
Common Stock, par value $.01 per share
(e) CUSIP Number:
00753W 20 7
Item 3. If this statement is filed pursuant to Rule 13d-1(b) or 13d-2(b),
check whether the person is a:
Not Applicable
Item 4. Ownership
(a) Amount Beneficially Owned as of December 31, 1995:
984,366.75 Shares
Page 4 of 6 Pages
(b) Percent of Class:
36.6%
(c) (i) Sole Power to Vote or to Direct to Vote:
984,366.75 Shares
(ii) Shared Power to Vote or to Direct the Vote:
(iii) Sole Power to Dispose or to Direct the Disposition of:
619,666.75 Shares
(iv) Shared Power to Dispose or to Direct the Disposition of:
None
The above shares do not include options for 150,000 shares, the
vesting and exercise formula and schedule of which are set forth in
the Issuer's Amended and Restated Stock Option Plan.
Item 5. Ownership of Five Percent or Less or a Class.
Not Applicable
Item 6: Ownership of More than Five Percent on Behalf of Another Person.
Item 4(c)(i) includes 364,700 shares which are subject to a
Voting Trust Agreement pursuant to which Mr. Groff has the power to
vote such shares. Dr. Steven Berkowitz, a citizen of the United
States of America whose residence address is 22 Malke Drive,
Wayside, New Jersey 07712, has the right to receive dividends from,
and proceeds from the sale of, 264,200 of such shares, or
approximately 9.95% of the class. Six employees of the Issuer have
the right to receive dividends from, and proceeds from the sale of,
an aggregate of 100,500 additional such shares. Deborah Riente,
the Secretary of the Issuer, has the right to receive dividends
from, and the proceeds of, the sale of 10,424 additional such
shares.
Page 5 of 6 Pages
Item 7. Identification and Classification of the Subsidiary Which Acquired
the Security Being Reported on by the Parent Holding Company.
Not Applicable
Item 8. Identification and Classification of Members of the Group.
Not Applicable
Item 9. Notice of Dissolution of Group.
Not Applicable
Item 10. Certification.
Not Applicable
Page 6 of 6 Pages
SIGNATURE
After reasonable inquiry and to the best of knowledge and belief,
I certify that the information set forth in this Statement is true, complete
and correct.
/s/CLARENCE P. GROFF February 14, 1996
CLARENCE P. GROFF
<PAGE>
OMB APPROVAL
OMB Number. 3235-0145
Expires: Oct. 31, 1994
Estimated average burden
hours per response..14.90
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
Under the Securities Exchange Act of 1934
(Amendment No. 7)*
Advanced Medical Products Inc.
(Name of Issuer)
Common Stock, $0.01 par value
(Title of Class of Securities)
00753W 20 7
(CUSIP Number)
Check the following line if a fee is being paid with this statement .
(A fee is not required only if the filing person: (1) has a previous
statement on file reporting beneficial ownership of more than five percent of
the class of securities described in Item 1; and (2) has filed an amendment
subsequent thereto reporting beneficial ownership of five percent or less of
such class.) (See Rule 13d-7).
*The remainder of this cover page shall be filled out for a reporting
person's initial filing on this form with respect to the subject class of
securities, and for any subsequent amendment containing information which
would alter the disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not be
deemed to be "filed" for the purpose of Section 18 of the Securities Exchange
Act of 1934 ("Act") or otherwise subject to the liabilities of that section
of the Act but shall be subject to all other provisions of the Act (however,
see the Notes).
Page 1 of 6 pages
CUSIP No. 00753W 20 7 13G Page 2 of 6 pages
1. Name of Reporting Person
S.S. or I.R.S. Identification No. of Above Person
Mr. George L. Down
2. Check the appropriate line if a member of a group*
(a)
(b) X
3. SEC Use Only
4. Citizenship or Place of Organization
United States of America
Number Of 5. Sole Voting Power
Shares 162,214.75
Beneficially 6. Shared Voting Power
Owned By 34,552
Each 7. Sole Dispositive Power
Reporting 162,214.75
Person 8. Shared Dispositive Power
With 14,976
9. Aggregate Amount Beneficially Owned by Each Reporting Person
196,766.75
10. Check if the Aggregate Amount in Row (9) Excludes Certain Shares*
11. Percent of Class Represented by Amount in Row 9
7.32%
12. Type of Reporting Person*
IN
Page 3 of 6 Pages
Item 1.
(a) Name of Issuer:
Advanced Medical Products Inc.
(b) Address of Issuer's Principal Executive Offices:
111 Research Drive
Columbia, South Carolina 29203
Item 2.
(a) Name:
Mr. George L. Down
(b) Address of Principal Business Office:
111 Research Drive
Columbia, South Carolina 29203
(c) Citizenship
United States of America
(d) Title of Class of Securities:
Common Stock, par value $.01 per share
(e) CUSIP Number:
00753W 20 7
Item 3. If this statement is filed pursuant to Rule 13d-1(b) or 13d-2(b),
check whether the person is a:
Not Applicable
Item 4. Ownership
(a) Amount Beneficially Owned as of December 31, 1995:
196,766.75 Shares
Page 4 of 6 Pages
(b) Percent of Class:
7.32%
(c) (i) Sole Power to Vote or to Direct to Vote:
162,214.75 Shares
(ii) Shared Power to Vote or to Direct the Vote:
34,552 Shares
(iii) Sole Power to Dispose or to Direct the Disposition of:
162,214.75 Shares
(iv) Shared Power to Dispose or to Direct the Disposition of:
14,976 Shares
Item 5. Ownership of Five Percent or Less or a Class.
Not Applicable
Item 6: Ownership of More than Five Percent on Behalf of Another Person.
Mr. Down holds a Power of Attorney to vote 14,976 shares owned
by an immediate family member. The foregoing shares are included
in the responses to Items 4(c)(ii) and 4(c)(iv). Mr. Down also
holds proxies to vote another 19,576 shares owned by immediate
family members. The foregoing shares are included in the responses
to Items 4(c)(ii).
Item 7. Identification and Classification of the Subsidiary Which Acquired
the Security Being Reported on by the Parent Holding Company.
Not Applicable
Item 8. Identification and Classification of Members of the Group.
Not Applicable
Page 5 of 6 Pages
Item 9. Notice of Dissolution of Group.
Not Applicable
Item 10. Certification.
Not Applicable
Page 6 of 6 Pages
SIGNATURE
After reasonable inquiry and to the best of knowledge and belief,
I certify that the information set forth in this Statement is true, complete
and correct.
/s/GEORGE L. DOWN February 14, 1996
GEORGE L. DOWN